Abstract:Exquisite binding specificity is essential for many protein functions but is difficult to engineer. Many biotechnological or biomedical applications require the discrimination of very similar ligands, which poses the challenge of designing protein sequences with highly specific binding profiles. Experimental methods for generating specific binders rely on in vitro selection, which is limited in terms of library size and control over specificity profiles. Additional control was recently demonstrated through high-throughput sequencing and downstream computational analysis. Here we follow such an approach to demonstrate the design of specific antibodies beyond those probed experimentally. We do so in a context where very similar epitopes need to be discriminated, and where these epitopes cannot be experimentally dissociated from other epitopes present in the selection. Our approach involves the identification of different binding modes, each associated with a particular ligand against which the antibodies are either selected or not. Using data from phage display experiments, we show that the model successfully disentangles these modes, even when they are associated with chemically very similar ligands. Additionally, we demonstrate and validate experimentally the computational design of antibodies with customized specificity profiles, either with specific high affinity for a particular target ligand, or with cross-specificity for multiple target ligands. Overall, our results showcase the potential of leveraging a biophysical model learned from selections against multiple ligands to design proteins with tailored specificity, with applications to protein engineering extending beyond the design of antibodies. A great challenge in protein science is to relate sequences to physical properties, both to predict physical properties from sequences, and to design sequences with desired phenotypes. A promising solution lies in integrating large-scale selection experiments, high-throughput sequencing, and machine learning techniques. However, existing models often focus solely on the property under selection ("fitness"), lacking interpretability. This limits our fundamental understanding of proteins and our ability to engineer them for desired properties, especially those not directly selectable in experiments. Previous studies have shown that incorporating biophysical constraints into models can offer quantitative insights, particularly in transcription factors Here, we demonstrate that when coupled with extensive experiments, such modeling can not only predict physical features but also design new proteins with specific properties. Our demonstration involves a problem of primary biotechnological and biomedical interest: the design of antibodies with defined specificity profiles. We focus on one of the most challenging tasks in the field, designing antibodies capable of discriminating between structurally and chemically similar ligands. This approach has applications for creating antibodies with both specific and cross-specific binding properties and for mitigating experimental artifacts and biases in selection experiments. The combination of biophysics-informed modeling and extensive selection experiments holds broad applicability beyond antibodies, offering a powerful toolset for designing proteins with desired physical properties.

Physical epistatic landscape of antibody binding affinity

Learning the heterogeneous hypermutation landscape of immunoglobulins from high-throughput repertoire data

Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves

Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody

Antigen–Antibody Interactions and Structural Flexibility of a Femtomolar-Affinity Antibody

Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space

Thermodynamic and Binding Effects of Antibody Affinity Maturation

Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability

Biochemical and biophysical characterization of natural polyreactivity in antibodies

Molecular tug of war reveals adaptive potential of an immune cell repertoire

Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability

Energy landscapes of peptide-MHC binding

Mutability and hypermutation antagonize immunoglobulin codon optimality

Diversity against adversity: How adaptive immunity evolves potent antibodies

Addressing the antibody germline bias and its effect on language models for improved antibody design

AlphaBind, a Domain-Specific Model to Predict and Optimize Antibody-Antigen Binding Affinity

Understanding Antibody-Target Antigen Interactions and the Avidity Effect Using Mathematical Modelling

Learning the Language of Antibody Hypervariability

Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

Inference and design of antibody specificity: From experiments to models and back